How much funding has Affect Therapeutics raised?

Affect Therapeutics has raised $48.0M in total funding, most recently a Series B round.

Who are Affect Therapeutics's investors?

Affect Therapeutics's investors include Artis Ventures (AV), Allumia Ventures, City Light Capital, LifeArc, AlleyCorp, Limitless Ventures.

When was Affect Therapeutics founded?

Affect Therapeutics was founded in 2020.

Where is Affect Therapeutics headquartered?

Affect Therapeutics is headquartered in McLean, Virginia, United States.

What industry is Affect Therapeutics in?

Affect Therapeutics operates in Healthcare.

How many employees does Affect Therapeutics have?

Affect Therapeutics has 11-50 employees.

Affect Therapeutics

One app. One team. One powerful playbook for feeling better.

McLean, United States · Founded 2020 · $48.0M raised

Healthcare

Headquarters: McLean, Virginia
Employees: 11–50
Founded: 2020
Business Model: B2C

Website: affecttherapeutics.com
Total Funding: $48.0M
Last Round: $26.0M Series BSep 2025
Rounds: 3

About

Affect Therapeutics is a nationally-scaled, online provider of therapy and psychiatric services for mental health and substance use disorders. Its smartphone app delivers a comprehensive treatment program combining counseling, medication management, peer support, and a science-backed contingency management rewards system that incentivizes healthy behaviors. The company works primarily with Medicaid recipients.

Summary

Affect Therapeutics is a Healthcare company based in McLean, United States, founded in 2020. It has raised $48.0M in total across 3 rounds, most recently a $26.0M Series B round in Sep 2025. Investors include Artis Ventures (AV), Allumia Ventures and City Light Capital.

LinkedIn X (Twitter)